Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, and Cancer Genomics and Diagnostics.
Histological Features of Lung Squamous Cell Carcinoma According to Radiological Early-Phase Progression Patterns.
Late-Onset Bilateral Malignant Ciliary Body Medulloepithelioma in an Adult.
Differential Expression of CD79B, CD19, and PD-L1 in de Novo and Transformed CD20-Negative Large B-Cell Lymphomas.
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study.
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case series.
Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG-TOP2 Study.
Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer.
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer
The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker Testing
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.
Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes.
50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data.
Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour.
Unveiling the molecular and clinical risk landscape of second primary lung cancer in resected non-small cell lung cancer.
EGFR mutation testing across the osimertinib clinical program.
Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types.
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data
Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing.
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities.
Flat Cell Variant of Lung Adenocarcinoma In Situ.
Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones.
Nationwide Real-World Usage of Blood-Based (Liquid) Biomarker Testing in Japan.
Clinicopathological and molecular characterization of KRAS wild-type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes.
Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance.
Dynamic nature of hepatic differentiation in lung adenocarcinoma.
Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance.
Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR).